5195results about "Group 3/13 element organic compounds" patented technology

The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.

Provided herein are polymorphs and crystalline forms of 2-fluoro-5-((5S,5aS,6S,9R)-1-fluoro-12-(((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)-5-methyl-5a,6,7,8,9,10-hexahydro-5H-4-oxa-3,10a,11,13,14-pentaaza-6,9-methanonaphtho[1,8-ab]heptalen-2-yl)-3-methyl-4-(trifluoromethyl)aniline (Compound of Formula (I)), pharmaceutical compositions thereof, and methods of their use, for example, in the treatment of cancer. Also provided herein are synthetic processes for the manufacture of a compound of Formula (I) (i.e., 2-fluoro-5-((5S,5aS,6S,9R)-1-fluoro-12-(((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)-5-methyl-5a,6,7,8,9,10-hexahydro-5H-4-oxa-3,10a,11,13,14-pentaaza-6,9-methanonaphtho[1,8-ab]heptalen-2-yl)-3-methyl-4-(trifluoromethyl)aniline). Also provided are compounds useful in its synthesis (e.g., those of Formulae (A), (B), (By), and (H)) and synthetic processes directed thereto.

The invention discloses a self-assembled monomolecular layer hole transport material, a hole transport layer and a battery thereof. According to the present invention, the compound having different anchoring groups and represented by the formula (I) can be subjected to firm self-assembly with the substrate surface through the chemical bonding manner, such that the good coverage rate is provided, the film forming quality is increased, and the transmission performance is improved; and meanwhile, the material has a rigid conjugate large-plane condensed ring core structure, so that the hole transmission performance of the material is ensured, and the photovoltaic performance is favorably improved. When the material is applied to a perovskite solar cell to prepare a hole transport layer, the hole extraction capability can be enhanced, and the open-circuit voltage, the filling factor and the photoelectric conversion efficiency of a device can be improved.

The invention belongs to the technical field of flame-retardant materials, and particularly relates to a phenylboronic acid-based P / N / B-containing halogen-free flame retardant, a preparation method thereof and application of the phenylboronic acid-based P / N / B-containing halogen-free flame retardant in epoxy resin. The preparation method comprises the following steps: by taking diphenyl hypophosphorous chloride as a basis, preparing a flame-retardant intermediate through nucleophilic substitution reaction between diphenyl hypophosphorous chloride and an aldehyde group-containing phenolic compound, then reacting a phenylboronic acid structure with 3-amino-1, 2-propylene glycol to obtain an amino group-containing phenylboronic acid compound, and finally reacting the phenylboronic acid compound with 3-amino-1, 2-propylene glycol to obtain the amino group-containing phenylboronic acid compound. And finally, carrying out a Schiff base reaction on the flame-retardant intermediate and an amino-containing phenylboronic acid compound to obtain the halogen-free flame retardant containing phosphorus, nitrogen and boron elements. The flame retardant provided by the invention can significantly improve the flame retardant property and mechanical property of epoxy resin. A flame-retardant epoxy resin prepared based on the flame retardant; the influence on Tg of an epoxy resin cured product is small, the smoke suppression and char formation performance and the mechanical performance of the cured product can be remarkably improved, and meanwhile, the flame retardant has excellent flame retardant efficiency; the limit oxygen index of the flame-retardant epoxy resin can reach 31%; the vertical combustion grade is V-0 or above, and the carbon residue amount can reach 18% or above.

The invention provides a boron-nitrogen heterocyclic compound as well as an intermediate and a preparation method thereof, the boron-nitrogen heterocyclic compound has a structure as shown in a general formula (1), and is prepared by taking compounds as shown in a formula A, a formula B and a formula C as intermediates. Compared with similar carbon skeleton molecules, the boron-nitrogen heterocyclic compound provided by the invention shows an excellent narrow-band luminescence property. The half-peak width of the emission spectrum of the boron-aza compound is as low as 6.4 nm, and meanwhile, the fluorescence quantum yield is as high as 97%.

The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I):tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.

Provided is a light emitting device including a first electrode, a second electrode, and an emission layer between the first electrode and the second electrode, and the emission layer may include a condensed cyclic compound represented by Formula 1 below, thereby exhibiting high luminous efficiency and improved service life characteristics.

The invention relates to an organic compound, a solar cell and application thereof. The organic compound is shown as a formula (1), wherein Ar is selected from any one of substituted or unsubstituted aryl with the ring-forming atom number of 6-50, substituted or unsubstituted heteroaryl with the ring-forming atom number of 5-50, a group shown as a formula (A) and a group shown as a formula (B), Ar'is selected from an electrically neutral organic group, and L is selected from a paraffin subunit with the carbon atom number of 1-10; r1 is an oxyacid group; n1 is selected from any integer of 1-3, and m1 is selected from any integer of 1-10; or the organic compound is an oxyacid radical salt of the compound as shown in the formula (1). The organic compound not only can be used as a passivation material, but also can be used as a hole transport material, and can improve the photoelectric conversion efficiency of a solar cell when being applied to preparation of the solar cell.

A compound of Chemical Formula 1 and an organic light emitting device including the same are provided. The compound is used as a material of an organic material layer of the organic light emitting device, and provides high color purity, high efficiency and enhanced lifetime properties.

Compounds of formula (II) and formula (I) which are inhibitors of QPCTL and QPCT: (II) and (I) are provided herein. Also provided are pharmaceutical compositions containing this compound, as well as compounds for use in methods of treating cancer, neurodegenerative, inflammatory or autoimmune diseases. Exemplary compounds are, for example, 3-(6-fluoropyridin-3-yl)-2-[4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]benzonitrile (Example 1): (1), and pharmacological data are provided. TIFF2025524039000368.tif70128

The invention belongs to the technical field of organic light-emitting materials, and relates to a boron-containing polycyclic compound for an organic light-emitting material. According to the invention, aryl or heteroaryl is taken as a center, 2-3 boron atoms are introduced and form covalent bonds with atoms such as N, O, S and Se, and a rigid polycyclic compound is constructed. The compound provided by the invention is a boron-containing polycyclic compound with multiple resonance effects, can realize narrow-spectrum and high-color-purity luminescence, also has efficient TADF characteristics, and significantly improves the performance of OLED devices. Compared with the prior art, the compound has remarkable advantages in the aspects of molecular structure design, photoelectric property regulation and control, application range and the like, provides important technical support for development of new-generation high-performance OLED materials, and has wide market prospects and application potential.

A compound or molecular complex. The compound or molecular complex comprises: a metal chelator configured for chelation with a radioactive isotope or a non-radioactive isotope; and a trifluoroborate (BF3)-containing moiety configured for 19F / 18F exchange or a precursor thereof; and optionally a cell-targeting domain.

The invention discloses a method for synthesizing deuterated olefin under catalysis of a palladium membrane by taking D2O as a deuterium source, and belongs to the technical field of synthesis of deuterated olefin building blocks. According to the method, a three-chamber electrolytic tank separated by a palladium membrane and an ion exchange membrane is used as a reactor, the palladium membrane is used as a working electrode, an electrolyte deuterium aqueous solution is used as an electrolyte, deuterium water is electrolyzed through a constant-potential electrolysis method, and formed active deuterium is transmitted to one side of an organic reaction taking absolute ethyl alcohol or cyclohexane as an organic solvent; and catalyzing an alkyne compound by using a palladium membrane modified by sodium thiophenol to perform reduction deuterization so as to synthesize a deuterated olefin compound with high selectivity, and further synthesizing a corresponding deuterated drug. The invention provides a green, efficient, high-universality and low-cost amplification synthesis method for synthesizing a deuterated olefin building block containing a functional group easy to reduce and hydrolyze, and the method has a wide application prospect.

The invention discloses a graphite piece silicon carbide coating and a preparation method thereof, and belongs to the technical field of inorganic non-metallic materials. The method comprises the following steps: firstly, carrying out surface polishing, cleaning and drying pretreatment on a graphite piece; then a solution containing phosphinazine functionalized silazane and a boron-silicon carlamide compound is adopted for spraying the pretreated graphite piece, drying and curing are conducted, and a surface modification layer is formed; and finally, placing the surface-modified graphite piece in chemical vapor deposition equipment, and depositing at specific temperature, pressure and atmosphere to form the silicon carbide coating. According to the method, uniform nucleation and crystallization of the silicon carbide coating are effectively promoted through unique surface modification treatment, and the compactness and uniformity of the coating and the binding force of the coating and a matrix are remarkably improved. The obtained coating graphite piece has excellent thermal corrosion resistance, oxidation resistance and mechanical property, the service life and the use frequency of the coating graphite piece in semiconductor epitaxial equipment are remarkably prolonged, the whole preparation process is environmentally friendly, and the coating graphite piece is suitable for coating treatment of a large graphite base material.

The invention relates to the technical field of preparation of organic photoelectric materials, in particular to a boron-nitrogen compound and an organic electroluminescent device comprising the same. The boron-nitrogen compound disclosed by the invention has good electron and hole receiving capability, and interaction among luminescent molecules can be effectively inhibited by introducing a large-steric-hindrance double-spiro group. Specifically, the boron-nitrogen compound provided by the invention is used as a functional layer, especially as an organic electroluminescent device manufactured by a luminescent layer, the current efficiency is improved, the efficiency of the device is greatly improved, and the service life of the device is greatly prolonged. Therefore, after most electrons and holes are compounded, energy is effectively transferred to the boron-nitrogen compound, so that high luminous efficiency is realized.

The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule includes or consists of a structure represented by Formula IwhereinR1 is selected from the group consisting of hydrogen and C6-C12-aryl, which is optionally substituted with one or more C1-C6-alkyl substituents, andRa is at each occurrence independently selected from the group consisting of: hydrogen, deuterium, N(R5)2, OR5, Si(R5)3, B(OR5)2, B(R5)2, OSO2R5, CF3, CN, F, Br, I, C1-C40-alkyl, C1-C40-alkoxy, C1-C40-thioalkoxy, C2-C40-alkenyl, C2-C40-alkynyl, C6-C60-aryl, and C2-C57-heteroaryl.

The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2,2′,2″-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-fluorophenol), useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.

Processes for preparing Compound I, and pharmaceutically acceptable salts and solvates thereof, pharmaceutically acceptable solid (e.g., crystalline or amorphous) forms of Compound I, pharmaceutical compositions comprising the same, methods of treating pain using the same, and methods for making the same are disclosed.

The invention discloses a boron-containing compound and a preparation method thereof. The invention provides a compound as shown in a formula 5. The compound can be used for synthesizing the compound shown in the formula I. The compound shown in the formula I is low in toxicity to tumor cells and can be combined with boron neutron capture therapy for targeted cancer treatment. # imgabs0 #

The invention relates to an organic compound, application of the compound and an organic electroluminescent device containing the compound. The organic compound has a structure as shown in formula (1), ring A, ring B, ring C, ring D, ring E, ring F, ring G, ring H and ring I independently represent one of C6-C60 aromatic rings and C5-C60 heteroaromatic rings, at least one of the ring E and the ring F is a naphthalene ring, and at least one of the ring G and the ring H is a naphthalene ring; w1, W2 and W3 are respectively and independently selected from a single bond, O, CO, SO2, S, NR1, CR2R3 or SiR4R5; and m1, m2 and m3 are respectively and independently 0 or 1. After the compound is prepared and applied to the organic electroluminescent device, the device has good performance of high color purity and high luminous efficiency, meanwhile, low-efficiency roll-off of the electroluminescent device is achieved, and the service life of the device is extremely long.

The invention discloses a dual-mechanism antibacterial photosensitizer as well as a preparation method and application thereof, and relates to the technical field of biomedical photoelectric functional materials. The invention relates to a triphenylamine derivative, which can realize fluorescence imaging of bacterial or fungal infection by utilizing fluorescence characteristics, can generate active oxygen under illumination to play a photodynamic therapy role, is suitable for preparing photodynamic therapy preparations and developing antibacterial materials, and can also be applied to the fields of environment and public health and tumor treatment. The problems that an existing photosensitizer is insufficient in broad spectrum, different in fungus drug resistance mechanism, limited in single treatment effect and the like can be effectively solved, and the photosensitizer has wide application prospects.

The invention provides a preparation method of 3-boron-L-phenylalanine or a derivative of 3-boron-L-phenylalanine. The preparation method provided by the invention comprises the step of preparing 3-boron-L-phenylalanine as shown in a formula (VI) or a derivative thereof by taking a compound as shown in a formula (III) as a raw material. The method has the advantages of mild reaction conditions, short route, high yield, few byproducts and low cost, and does not need an extremely low temperature condition process or complicated purification steps. # imgabs0 #

The present invention provides a compound having methyltransferase inhibitory activity. Specifically, the present invention provides a compound having PRMT5 inhibitory activity. The compound can be used for the preparation of a pharmaceutical composition for treating PRMT5 activity-related diseases. Formula I, Formula II.

The invention belongs to the technical field of organic synthesis, and particularly discloses an ammonia aromatic alkene modified near-infrared BODIPY fluorescent probe as well as a preparation method and application thereof.The near-infrared BODIPY fluorescent probe is obtained by adopting 6-(dimethylamino) nicotinic aldehyde to directionally modify the alpha position of BODIPY and constructing an expanded conjugated system through Knoevenagel condensation. Wherein dimethylamino provides a strong electron donating effect, a molecular structure is twisted into a non-planar configuration due to steric hindrance of a pyridine ring, pi-pi accumulation is reduced, and an ACQ effect is inhibited. According to the structural modification strategy, significant red shift of absorption / emission wavelength is realized by expanding a molecular pi-conjugated skeleton, and meanwhile, the stability of the BODIPY core and the quantum yield are effectively enhanced. The probe molecule can specifically recognize the diphenylalanine dipeptide structural unit by utilizing the synergistic coordination effect of the 2-aminopyridine derivative and the BODIPY mother nucleus, so that the selective detection of the Alzheimer's disease biomarker Abeta42 is realized, and a novel optical detection tool is provided for the early molecular diagnosis and targeted therapy of AD (Alzheimer's disease).

A class of aromatic hydrocarbon receptor modulator compounds represented by the following formula I, or respective optical isomers, deuterated compounds, prodrugs or pharmaceutically acceptable salts thereof, and a preparation method therefor and the use thereof. The compounds can be used as aromatic hydrocarbon receptor modulators to regulate the activity of aromatic hydrocarbon receptors in vivo, which is of great significance for the treatment of related diseases such as immune diseases, inflammatory diseases, infections, skin diseases, osteoporosis, cancers and neurodegenerative diseases.

The invention discloses a reprocessable solid-solid phase change material based on dynamic borate bonds and a preparation method of the reprocessable solid-solid phase change material. Based on the mechanism that boric acid ester is subjected to ester exchange during thermal stimulation, a dynamic cross-linking agent containing boric acid ester is adopted for cross-linking a polyurethane prepolymer, polyethylene glycol is cross-linked through chemical bonds, the tensile strength and the elongation at break of the phase change material are improved, and the problem that the phase change material is prone to leakage in the phase change process is solved; besides, borate bonds belong to associated dynamic covalent bonds and can keep the crosslinking density of the material unchanged when ester exchange occurs under thermal stimulation, so that the thermal stability of the material is relatively good; the solid-solid phase change material disclosed by the invention is excellent in mechanical property, has a relatively high enthalpy value, can be reprocessed, and has an application prospect in the fields of thermal management, energy storage, infrared stealth and the like.

Disclosed herein are activatable inactive sonosensitizer compounds, referred to as locked sonosensitizer compounds, designed with a detachable stimuli-responsive tether acting as a trigger or safety, as these compounds restore their inherent sonosensitization activity upon the detachment of the tether. The invention further encompasses pharmaceutical compositions comprising the same, offering a strategic approach to sonodynamic therapy, whereas the compounds and compositions are formulated to be administered and applied under favorable conditions, enhancing their efficacy in the context of therapeutic applications, since the therapeutic methods presented herein are more versatile and efficient compared to presently known SDT methods due to the controlled activation of the sonosensitizer.

An organic light-emitting element according to the present invention employs a polycyclic aromatic derivative compound in a light-emitting layer inside the element, and further comprises a capping layer. Thus, the organic light-emitting element can be made highly efficient and can be useful for a device selected from among a flat panel display device, a flexible display device, a monochrome or white flat panel lighting device, and a monochrome or white flexible lighting device.